{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:06Z","timestamp":1786120206315,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/olq.0b013e31822c664f","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T04:50:42Z","timestamp":1312865442000},"page":"892-898","source":"Crossref","is-referenced-by-count":36,"title":["Trends in Antimicrobial Resistance in Neisseria gonorrhoeae Isolated in Canada: 2000\u20132009"],"prefix":"10.1097","volume":"38","author":[{"given":"Irene","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-2-20210213","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/sti.2010.042648","article-title":"The Gonococcus fights back: Is this time a knock out?","volume":"86","author":"Lewis","year":"2010","journal-title":"Sex Transm Infect"},{"key":"R4-2-20210213","doi-asserted-by":"crossref","first-page":"606","DOI":"10.7326\/0003-4819-148-8-200804150-00005","article-title":"Emerging antimicrobial resistance in Neisseria gonorrhoeae: Urgent need to strengthen prevention strategies.","volume":"148","author":"Workowski","year":"2008","journal-title":"Ann Intern Med"},{"key":"R5-2-20210213","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1503\/cmaj.045088","article-title":"Gonorrhea treatment guidelines in Canada: 2004 Update.","volume":"171","author":"Mann","year":"2004","journal-title":"CMAJ"},{"key":"R6-2-20210213","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1503\/cmaj.080222","article-title":"Prevalence of and risk factors for quinolone-resistant Neisseria gonorrhoeae infection in Ontario.","volume":"180","author":"Ota","year":"2009","journal-title":"CMAJ"},{"key":"R7-2-20210213","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/OLQ.0b013e3181aad9df","article-title":"Antimicrobial resistance in gonorrhea: The influence of epidemiologic and laboratory surveillance data on treatment guidelines: Alberta, Canada 2001\u20132007.","volume":"36","author":"Singh","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R8-2-20210213","first-page":"872","article-title":"Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada.","volume":"168","author":"Sarwal","year":"2003","journal-title":"CMAJ"},{"key":"R11-2-20210213","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/JB.85.6.1274-1279.1963","article-title":"Neisseria gonorrhoeae I. Virulence genetically linked to clonal variation.","volume":"85","author":"Kellogg","year":"1963","journal-title":"J Bacteriol"},{"key":"R12-2-20210213","article-title":"Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement M100-S20.","year":"2010"},{"key":"R13-2-20210213","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00007435-199607000-00004","article-title":"A clinical isolate of Neisseria gonorrhoeae with in vitro resistance to erythromycin and decreased susceptibility to azithromycin.","volume":"23","author":"Ehret","year":"1996","journal-title":"Sex Transm Dis"},{"key":"R14-2-20210213","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00007435-199811000-00002","article-title":"Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters.","volume":"25","author":"Tapsall","year":"1998","journal-title":"Sex Transm Dis"},{"key":"R16-2-20210213","first-page":"1","article-title":"Recombinant DNA Methodology.","author":"Dillon","year":"1985"},{"key":"R17-2-20210213","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/01.OLQ.0000099560.11350.1A","article-title":"Trends of chromosomally mediated antimicrobial resistance in Neisseria gonorrhoeae in Canada: 1994\u20131999.","volume":"30","author":"Ng","year":"2003","journal-title":"Sex Transm Dis"},{"key":"R19-2-20210213","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/OLQ.0b013e3181cfca06","article-title":"Trends in antimicrobial susceptibility of Neisseria gonorrhoeae in Israel, 2002 to 2007, with special reference to fluoroquinolone resistance.","volume":"37","author":"Dan","year":"2010","journal-title":"Sex Transm Dis"},{"key":"R20-2-20210213","first-page":"332","article-title":"Update to CDC's Sex Transm Dis Treatment Guidelines, 2006: Fluoroquinolones No Longer Recommended for Treatment of Gonococcal Infections.","volume":"56","year":"2007","journal-title":"MMWR"},{"key":"R21-2-20210213","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/jac\/dkq377","article-title":"Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.","volume":"65","author":"Whiley","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R22-2-20210213","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/sti.2010.045377","article-title":"Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden.","volume":"86","author":"Golparian","year":"2010","journal-title":"Sex Transm Infect"},{"key":"R23-2-20210213","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/jac\/dkq289","article-title":"Cephalosporin MIC creep among gonococci: Time for a pharmacodynamic rethink?","volume":"65","author":"Chisholm","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R24-2-20210213","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3201\/eid1701.100397","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.","volume":"17","author":"Ohnishi","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R25-2-20210213","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-149-5-200809020-00025","article-title":"Lack of nationwide surveillance of antimicrobial resistance of Neisseria gonorrhoeae in Japan.","volume":"149","author":"Deguchi","year":"2008","journal-title":"Ann Intern Med"},{"key":"R28-2-20210213","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1128\/AAC.00482-10","article-title":"Characteristics and dissemination of mosaic penicillin-binding protein 2-harboring multidrug-resistant Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility in Northern Taiwan.","volume":"54","author":"Huang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-2-20210213","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/AAC.00406-09","article-title":"Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California.","volume":"53","author":"Pandori","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R30-2-20210213","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1128\/AAC.01604-06","article-title":"Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: Association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.","volume":"51","author":"Lindberg","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R31-2-20210213","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/AAC.00306-07","article-title":"Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone.","volume":"51","author":"Whiley","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R32-2-20210213","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14656560902731993","article-title":"The use of cephalosporins for gonorrhea: The impending problem of resistance.","volume":"10","author":"Barry","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"R33-2-20210213","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/dkp505","article-title":"Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.","volume":"65","author":"Lee","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R34-2-20210213","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10156-008-0610-7","article-title":"Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone.","volume":"14","author":"Osaka","year":"2008","journal-title":"J Infect Chemother"},{"key":"R35-2-20210213","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/eri.09.63","article-title":"Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.","volume":"7","author":"Tapsall","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R36-2-20210213","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.00304-09","article-title":"Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae.","volume":"53","author":"Zhao","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R37-2-20210213","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/AAC.46.9.2811-2820.2002","article-title":"Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae.","volume":"46","author":"Olesky","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-2-20210213","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1128\/JB.188.7.2300-2308.2006","article-title":"Porin-mediated antibiotic resistance in Neisseria gonorrhoeae: Ion, solute, and antibiotic permeation through PIB proteins with penB mutations.","volume":"188","author":"Olesky","year":"2006","journal-title":"J Bacteriol"},{"key":"R40-2-20210213","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jac\/dkn235","article-title":"Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland.","volume":"62","author":"Palmer","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R41-2-20210213","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/jac\/dkp118","article-title":"Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy.","volume":"63","author":"Starnino","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R42-2-20210213","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/OLQ.0b013e3181b61bb1","article-title":"Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina.","volume":"36","author":"Galarza","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R43-2-20210213","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1056\/NEJM198707303170504","article-title":"Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae.","volume":"317","author":"Boslego","year":"1987","journal-title":"N Engl J Med"},{"key":"R44-2-20210213","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/AAC.44.5.1365-1366.2000","article-title":"Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA.","volume":"44","author":"Galimand","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R45-2-20210213","first-page":"15","article-title":"The Russian gonococcal antimicrobial susceptibility programme (RU-GASP)\u2014national resistance prevalence in 2007 and 2008, and trends during 2005\u20132008.","author":"Kubanova","year":"2010","journal-title":"Euro Surveillance"},{"key":"R48-2-20210213","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/14787210.4.4.619","article-title":"Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: Some possible remedies.","volume":"4","author":"Tapsall","year":"2006","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/OLQ.0b013e31822c664f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:13:52Z","timestamp":1786047232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007435-201110000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e31822c664f","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}